ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide

C75H68F7N15O10 — CID 157054503

IUPACethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide
SMILESCCOC(N)=Nc1ncc(C#Cc2cc(NC(=O)c3cc(N4CCC[C@H](O)C4)cc(C(F)(F)F)c3)ccn2)o1.Cc1ccc(C(=O)Nc2cc(N3CCOC3=O)cc(C(F)(F)F)c2)cc1C#Cc1cnc(C(N)=O)o1.Cc1ccc(NC(=O)c2cc(F)cc(N3CCN(C)CC3)c2)cc1C#Cc1cncn1C
InChIInChI=1S/C26H25F3N6O4.C25H26FN5O.C24H17F3N4O5/c1-2-38-24(30)34-25-32-14-22(39-25)6-5-18-13-19(7-8-31-18)33-23(37)16-10-17(26(27,28)29)12-20(11-16)35-9-3-4-21(36)15-35;1-18-4-6-22(13-19(18)5-7-23-16-27-17-30(23)3)28-25(32)20-12-21(26)15-24(14-20)31-10-8-29(2)9-11-31;1-13-2-3-15(8-14(13)4-5-19-12-29-22(36-19)20(28)32)21(33)30-17-9-16(24(25,26)27)10-18(11-17)31-6-7-35-23(31)34/h7-8,10-14,21,36H,2-4,9,15H2,1H3,(H2,30,32,34)(H,31,33,37);4,6,12-17H,8-11H2,1-3H3,(H,28,32);2-3,8-12H,6-7H2,1H3,(H2,28,32)(H,30,33)/t21-;;/m0../s1
InChIKeyAAPATSLPFOQEQH-FGJQBABTSA-N
MW1472.45 g/mol
LogP10.67
Rot. Bonds12

About ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide

ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide (PubChem CID 157054503) has the molecular formula C75H68F7N15O10 and a molecular weight of 1472.45 g/mol. Its IUPAC name is ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide.

Molecular Properties

Compound Nameethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide
PubChem CID157054503
Molecular FormulaC75H68F7N15O10
Molecular Weight1472.45 g/mol
Exact Mass1471.52
IUPAC Nameethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide
SMILESCCOC(N)=Nc1ncc(C#Cc2cc(NC(=O)c3cc(N4CCC[C@H](O)C4)cc(C(F)(F)F)c3)ccn2)o1.Cc1ccc(C(=O)Nc2cc(N3CCOC3=O)cc(C(F)(F)F)c2)cc1C#Cc1cnc(C(N)=O)o1.Cc1ccc(NC(=O)c2cc(F)cc(N3CCN(C)CC3)c2)cc1C#Cc1cncn1C
InChIInChI=1S/C26H25F3N6O4.C25H26FN5O.C24H17F3N4O5/c1-2-38-24(30)34-25-32-14-22(39-25)6-5-18-13-19(7-8-31-18)33-23(37)16-10-17(26(27,28)29)12-20(11-16)35-9-3-4-21(36)15-35;1-18-4-6-22(13-19(18)5-7-23-16-27-17-30(23)3)28-25(32)20-12-21(26)15-24(14-20)31-10-8-29(2)9-11-31;1-13-2-3-15(8-14(13)4-5-19-12-29-22(36-19)20(28)32)21(33)30-17-9-16(24(25,26)27)10-18(11-17)31-6-7-35-23(31)34/h7-8,10-14,21,36H,2-4,9,15H2,1H3,(H2,30,32,34)(H,31,33,37);4,6,12-17H,8-11H2,1-3H3,(H,28,32);2-3,8-12H,6-7H2,1H3,(H2,28,32)(H,30,33)/t21-;;/m0../s1
InChIKeyAAPATSLPFOQEQH-FGJQBABTSA-N
XLogP10.67
TPSA320.26 Ų
H-Bond Donors6
H-Bond Acceptors19
Rotatable Bonds12
Heavy Atoms107
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001472.45
LogP ≤ 510.67
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide?
The IUPAC name of ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide (CID 157054503) is ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide.
What is the SMILES notation for ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide?
The canonical SMILES for ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide is CCOC(N)=Nc1ncc(C#Cc2cc(NC(=O)c3cc(N4CCC[C@H](O)C4)cc(C(F)(F)F)c3)ccn2)o1.Cc1ccc(C(=O)Nc2cc(N3CCOC3=O)cc(C(F)(F)F)c2)cc1C#Cc1cnc(C(N)=O)o1.Cc1ccc(NC(=O)c2cc(F)cc(N3CCN(C)CC3)c2)cc1C#Cc1cncn1C.
What is the InChIKey of ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide?
The InChIKey is AAPATSLPFOQEQH-FGJQBABTSA-N. The full InChI is InChI=1S/C26H25F3N6O4.C25H26FN5O.C24H17F3N4O5/c1-2-38-24(30)34-25-32-14-22(39-25)6-5-18-13-19(7-8-31-18)33-23(37)16-10-17(26(27,28)29)12-20(11-16)35-9-3-4-21(36)15-35;1-18-4-6-22(13-19(18)5-7-23-16-27-17-30(23)3)28-25(32)20-12-21(26)15-24(14-20)31-10-8-29(2)9-11-31;1-13-2-3-15(8-14(13)4-5-19-12-29-22(36-19)20(28)32)21(33)30-17-9-16(24(25,26)27)10-18(11-17)31-6-7-35-23(31)34/h7-8,10-14,21,36H,2-4,9,15H2,1H3,(H2,30,32,34)(H,31,33,37);4,6,12-17H,8-11H2,1-3H3,(H,28,32);2-3,8-12H,6-7H2,1H3,(H2,28,32)(H,30,33)/t21-;;/m0../s1.
What are the key properties of ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide?
ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide has a molecular weight of 1472.45 g/mol, XLogP of 10.67, 12 rotatable bonds, 6 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl N'-[5-[2-[4-[[3-[(3S)-3-hydroxypiperidin-1-yl]-5-(trifluoromethyl)benzoyl]amino]-2-pyridinyl]ethynyl]-1,3-oxazol-2-yl]carbamimidate;3-fluoro-N-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]-5-(4-methylpiperazin-1-yl)benzamide;5-[2-[2-methyl-5-[[3-(2-oxo-1,3-oxazolidin-3-yl)-5-(trifluoromethyl)phenyl]carbamoyl]phenyl]ethynyl]-1,3-oxazole-2-carboxamide is sourced from PubChem (CID 157054503), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).